Inferring tumour purity and stromal and immune cell admixture from expression data
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Infiltrating stromal and immune cells form the major fraction of normal cells in tumour tissue and not only perturb the tumour signal in molecular studies but also have an important role in cancer biology. Here we describe ‘Estimation of STromal and Immune cells in MAlignant Tumours using Expression data’ (ESTIMATE)—a method that uses gene expression signatures to infer the fraction of stromal and immune cells in tumour samples. ESTIMATE scores correlate with DNA copy number-based tumour purity across samples from 11 different tumour types, profiled on Agilent, Affymetrix platforms or based on RNA sequencing and available through The Cancer Genome Atlas. The prediction accuracy is further corroborated using 3,809 transcriptional profiles available elsewhere in the public domain. The ESTIMATE method allows consideration of tumour-associated normal cells in genomic and transcriptomic studies. An R-library is available on https://sourceforge.net/projects/estimateproject/ . Tumour biopsies contain contaminating normal cells and these can influence the analysis of tumour samples. In this study, Yoshihara et al.develop an algorithm based on gene expression profiles from The Cancer Genome Atlas to estimate the number of contaminating normal cells in tumour samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“this result is not merely a reflection of the extent of immune infiltration, as indicated by the lack of correlation between the γδ T cell signature score and ESTIMATE (Yoshihara et al., 2013) immune signature score for individual patients”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Yoshihara et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 2×
“We devised two gene signatures: (1) a ‘stromal signature’ that was designed to capture the presence of stroma in tumour tissue, and (2) an ‘immune signature’ that aimed to represent the infiltration of immune cells in tumour tissue (Supplementary Data 1).”
MethodRSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Cited by
Items 201–300 of 1,021
The molecular feature of macrophages in tumor immune microenvironment of glioma patients
Zhang, H., Luo, Y., Wu, W., Zhang, L., Wang, Z., Dai, Z., Feng, S., Cao, H., Cheng, Q., & Liu, Z. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.08.019 · Cited by 172
“Immune Score and Stromal Score serve to evaluate the infiltrating inflammatory cell density and stromal cell density within the tumor tissue [88].”
BackgroundLactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation
Wang, S., Huang, T., Wu, Q., Yuan, H., Wu, X., Yuan, F., Duan, T., Taori, S., Zhao, Y., Snyder, N. W., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci176851 · Cited by 158
Koncina, E., Nurmik, M., Pozdeev, V. I., Gilson, C., Tsenkova, M., Begaj, R., Stang, S., Gaigneaux, A., Weindorfer, C., Rodriguez, F., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39953-w · Cited by 161
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours
Melero, I., Luken, M. D. M., de Velasco, G., Garralda, E., Martín-Liberal, J., Joerger, M., Alonso, G., Goebeler, M.-E., Schüler, M., König, D., et al. (2024) · Nature · doi:10.1038/s41586-024-08305-z · Cited by 165
“Fractions of immune infiltrates and other cell types (including tumour and stromal cells) were estimated through quanTIseq 38,39 using the immunodeconv R package 40 on RNA-sequencing data (TPM) corrected for purity as determined by ESTIMATE 41 .”
Alonso, M. H., Aussó, S., López‐Doriga, A., Cordero, D., Guinó, E., Solé, X., Barenys, M., de, J., Capellá, G., Salazar, R., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.208 · Cited by 160
“The stromal proportion in each sample was calculated with the ESTIMATE R package from gene expression data (Yoshihara et al, 2013).”
MethodGao, Y., Li, X., Zeng, C., Liu, C., Hao, Q., Li, W., Zhang, K., Zhang, W., Wang, S., Zhao, H., et al. (2020) · Advanced Science · doi:10.1002/advs.202002518 · Cited by 160
Li, Y., Gu, J., Xu, F., Zhu, Q., Chen, Y., Ge, D., & Lu, C. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa225 · Cited by 168
Wang, Z., Wang, Y., Yang, T., Xing, H., Wang, Y., Gao, L., Guo, X., Xing, B., Wang, Y., & Ma, W. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab032 · Cited by 163
“Estimation of Stromal and Immune cells in Malignant Tumor tissues using Expression data (ESTIMATE) was employed to evaluate the tumor microenvironment and predict the tumor purity and abundances of intratumoral stromal and immune cells based on the gene expression profiles of GBM samples [27].”
MethodA multi-omic single-cell landscape of human gynecologic malignancies
Regner, M. J., Wisniewska, K., Garcia-Recio, S., Thennavan, A., Mendez-Giraldez, R., Malladi, V. S., Hawkins, G., Parker, J. S., Perou, C. M., Bae-Jump, V. L., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.10.013 · Cited by 135
Zhao, S., Wang, L., Ding, W., Ye, B., Cheng, C., Shao, J., Liu, J., & Zhou, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1180404 · Cited by 147
“Based on the expression profile, the R package “estimate” was used to infer the interstitial and immune cell abundance and tumor purity of malignant tumor tissue (28, 29).”
MethodStromal-Immune Score Based Gene Signature: A Prognosis Stratification Tool in Gastric Cancer
Wang, H., Wu, X., & Chen, Y. (2019) · Frontiers in Oncology · doi:10.2139/ssrn.3409287 · Cited by 182
Zheng, H., Liu, H., Li, H., Dou, W., Wang, J., Zhang, J., Liu, T., Wu, Y., Liu, Y., & Wang, X. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02913-0 · Cited by 160
“13), which were representative of the immune and stromal cellular infiltrations in each sample [36].”
BackgroundHu, Y., Pan, J., Shah, P., Ao, M., Thomas, S. N., Liu, Y., Chen, L., Schnaubelt, M., Clark, D. J., Rodriguez, H., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108276 · Cited by 157
“We also applied ESTIMATE (Yoshihara et al., 2013) on the protein expression of 5,916 proteins identified crossing all tumor samples in the GLOBAL dataset to estimate the stromal cell and immune cell influence on the clustering result (Figures S2C–S2E).”
MethodSelf-citationA proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population
Qu, Y., Feng, J., Wu, X., Bai, L., Xu, W., Zhu, L., Liu, Y., Xu, F., Zhang, X., Yang, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29577-x · Cited by 167
Zhang, N., Zhang, H., Wu, W., Zhou, R., Li, S., Wang, Z., Dai, Z., Zhang, L., Liu, F., Liu, Z., et al. (2022) · Theranostics · doi:10.7150/thno.74281 · Cited by 140
“…(ssGSEA) algorithm [18], Microenvironment Cell Populations-counter (MCPcounter) algorithm [20], and Estimation of STromal and Immune cells in MAlignant Tumours using Expression data (ESTIMATE) algorithm [21] were applied for calculating the abundance of immune infiltrating cells and ESTIMATE score.”
MethodHeeke, S., Gay, C. M., Estecio, M. R., Tran, H. T., Morris, B. B., Zhang, B., Tang, X., Raso, M. G., Rocha, P., Lai, S., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.01.001 · Cited by 154
“…SCLC-I, while the SCLC-P and SCLC-I subgroups were characterized by a higher expression of HLA genes, tumor inflammation genes (TIS) (Figure 1B) as well as a higher percentage of tumor stroma and, hence, a lower percentage of tumor cells (Figure 1C) as calculated using RNA-seq deconvolution 26 .”
Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
Sun, S., Guo, W., Wang, Z., Wang, X., Zhang, G., Zhang, H., Li, R., Gao, Y., Qiu, B., Tan, F., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3240 · Cited by 161
Knowledge Mapping of Immunotherapy for Hepatocellular Carcinoma: A Bibliometric Study
Shen, J., Shen, H., Ke, L., Chen, J., Dang, X., Liu, B., & Hua, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.815575 · Cited by 162
Self-citationProteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer
Anurag, M., Jaehnig, E. J., Krug, K., Lei, J. T., Bergstrom, E. J., Kim, B.-J., Vashist, T. D., Huynh, A. M. T., Dou, Y., Gou, X., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0200 · Cited by 147
“Immune profile and microenvironment scores were inferred from the FPKM version of the RNA-seq data using ESTIMATE (63), Cibersort (ref.”
MethodInfluentialLiao, C., & Wang, X. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05615-3 · Cited by 146
Zheng, X., Zhang, N., Wu, H.-J., & Wu, H. (2017) · Genome Biology · doi:10.1186/s13059-016-1143-5 · Cited by 134
“Estimating the “tumor purity”, or the percentage of cancer cells in a solid tumor sample, has been an active research topic [12, 13].”
BackgroundMethodInfluentialImmune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer
Wang, S., Zhang, Q., Yu, C., Cao, Y., Zuo, Y., & Yang, L. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa026 · Cited by 164
Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
Wu, L., Wu, W., Zhang, J., Zhao, Z., Li, L., Zhu, M., Wu, M., Wu, F., Zhou, F., Du, Y., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0196 · Cited by 171
Self-citationA population-level digital histologic biomarker for enhanced prognosis of invasive breast cancer
Amgad, M., Hodge, J. M., Elsebaie, M. A. T., Bodelon, C., Puvanesarajah, S., Gutman, D. A., Siziopikou, K. P., Goldstein, J. A., Gaudet, M. M., Teras, L. R., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02643-7 · Cited by 137
“…correlated with immune cell infiltration within the TNBC microenvironment, determined using the xCell genomic deconvolution assay ( r = −0.179, P = 0.039) or the immune score from estimation of stromal and immune cells in malignant tumor tissues using expression data ( r = −0.168, P = 0.05) 61,62 .”
InfluentialA Molecular Portrait of High-Grade Ductal Carcinoma In Situ
Abba, M. C., Gong, T., Lu, Y., Lee, J., Zhong, Y., Lacunza, E., Butti, M., Takata, Y., Gaddis, S., Shen, J., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0506 · Cited by 137
“We used the ESTIMATE algorithm(EstimationofSTromalandImmunecellsinMalignant TumorsusingExpressiondata)toinfertheimmuneandstromal components from each DCIS sample (30).”
InfluentialLyu, H., Li, M., Jiang, Z., Liu, Z., & Wang, X. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.07.009 · Cited by 111
“Wequantified the immune cell infiltration level of each HNSCC sample using the immune score evaluated by ESTIMATE [53].”
BackgroundMethodInfluentialSong, P., Li, W., Guo, L., Ying, J., Gao, S., & He, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.850745 · Cited by 154
“Estimation of Stromal and Immune Scores The ESTIMATE algorithm was employed to assess levels of stromal and immune cell infiltration using expression profiles by the “estimate” R package (44).”
MethodAutocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression
Kramer, N., Schmoellerl, J., Unger, C., Nivarthi, H., Rudisch, A., Unterleuthner, D., Scherzer, M., Riedl, A., Artaker, M., Crnčec, I., et al. (2017) · Oncogene · doi:10.1038/onc.2017.144 · Cited by 147
Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer
Jiang, Z., Liu, Z., Li, M., Chen, C., & Wang, X. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.07.012 · Cited by 119
“In addition, we used the ESTIMATE algorithm 5] to evaluate the levels of immune cell infiltration (immune score) in sc T th th ca im de a re Im A cy su ne tu th tu si ex In w co sh tu pa of ap es pa T ap ca th ti ne T p5 GC and found that the CIN GCs had significantly lower immune ores than the GS GCs (Figure 4D).”
InfluentialZhang, Z., Chen, L., Chen, H., Zhao, J., Li, K., Sun, J., & Zhou, M. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104207 · Cited by 160
Gerling, M., Büller, N. V. J. A., Kirn, L. M., Joost, S., Frings, O., Englert, B., Bergström, Å., Kuiper, R. V., Blaas, L., Wielenga, M. C. B., et al. (2016) · Nature Communications · doi:10.1038/ncomms12321 · Cited by 127
“Pre-calculated ESTIMATE scores for the TCGA colon adenocarcinoma data were retrieved from the ESTIMATE web repository (http://ibl.mdanderson.org/ estimate/) 60 .”
A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data
Falco, A. D., Caruso, F. P., Su, X., Iavarone, A., & Ceccarelli, M. (2023) · Nature Communications · doi:10.1038/s41467-023-36790-9 · Cited by 142
“A set of gene signatures from public collections 6,37 , including cells of the tumor microenvironment, stromal and immune cells, such as lymphocytes, macrophages, microglial cells, dendritic cells, neurons, and others (Supplementary Data 1), is used to identify the high-con fi dencenormalcells.”
MethodSun, Y., Wu, P., Zhang, Z., Wang, Z., Zhou, K., Song, M., Ji, Y., Zang, F., Lou, L., Rao, K., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.11.010 · Cited by 140
Gatto, F., Nookaew, I., & Nielsen, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319196111 · Cited by 132
“We inferred scores for tumor purity from gene expression profiles using ESTIMATE (17).”
BackgroundMethodLiu, L., Zhang, R., Deng, J., Dai, X., Zhu, X., Fu, Q., Zhang, H., Tong, Z., Zhao, P., Fang, W. J., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02967-8 · Cited by 139
“The ESTIMATE algorithm was performed to obtain an estimate score, stromal score and immune score based on the transcriptome data [13].”
MethodPrognostic analysis of cuproptosis-related gene in triple-negative breast cancer
Sha, S., Si, L., Wu, X., Chen, Y., Xiong, H., Xu, Y., Liu, W., Mei, H., Wang, T., & Li, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.922780 · Cited by 147
“The immune status and stromal scores, microsatellite instability (MSI), dysfunction, exclusion, and tumor immune dysfunction and exclusion (TIDE) total scores between the high- and low-risk groups were displayed as a violin chart using the ESTIMATE algorithm (22).”
MethodLiu, Y., Sun, Y., Wang, P., Li, S., Dong, Y., Zhou, M., Shi, B., Jiang, H., Sun, R., & Li, Z. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04080-z · Cited by 137
“The ESTIMATE algorithm was applied to estimate the tumor purity score [25].”
MethodUsing R and Bioconductor in Clinical Genomics and Transcriptomics
Sepulveda, J. L. (2019) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2019.08.006 · Cited by 154
Albacker, L. A., Wu, J., Smith, P., Warmuth, M., Stephens, P. J., Zhu, P., Yu, L., & Chmielecki, J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0176181 · Cited by 126
Liu, F., Qin, L., Liao, Z., Song, J., Yuan, C., Liu, Y., Wang, Y., Xu, H., Zhang, Q., Pei, Y., et al. (2020) · Experimental Hematology & Oncology · doi:10.1186/s40164-020-00165-3 · Cited by 126
“Then, we evaluated the immune state among three clusters with immune score and stromal score, calculated by ESTIMATE algorithm [41] to estimate infiltrating overall immune cells and stromal cells in tumor tissues.”
MethodChikina, M., Zaslavsky, E., & Sealfon, S. C. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv015 · Cited by 122
“Results: In this study, we consider a clinically relevant situation where neither accurate proportion estimates nor pure cell expression is of direct interest, but where we are rather interested in detecting and interpreting relevant differential expression in mixture samples.”
BackgroundTumor purity as a prognosis and immunotherapy relevant feature in gastric cancer
Gong, Z., Zhang, J., & Guo, W. (2020) · Cancer Medicine · doi:10.1002/cam4.3505 · Cited by 150
TIMER3: an enhanced resource for tumor immune analysis
Cui, H., Zhao, G., Lu, Y., Zuo, S., Duan, D., Luo, X., Zhao, H., Li, J., Zeng, Z., Chen, Q., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf388 · Cited by 146
García‐Recio, S., Hinoue, T., Wheeler, G. L., Kelly, B., Garrido-Castro, A. C., Pascual, T., de Cubas, A. A., Xia, Y., Felsheim, B., McClure, M. B., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00491-x · Cited by 193
Self-citationMao, Y., Feng, Q., Zheng, P., Yang, L., Liu, T., Xu, Y., Zhu, D., Chang, W., Ji, M., Tu, Y., et al. (2018) · Cancer Management and Research · doi:10.2147/cmar.s171855 · Cited by 151
“15,16 The expression profile of 141 stroma-related genes and 141 immune-related genes was analyzed, and tumor purity was estimated by combining stromal and immune scores.”
Lian, H., Han, Y., Zhang, Y., Zhao, Y., Yan, S., Li, Q., Wang, B., Wang, J., Meng, W., Yang, J., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12557 · Cited by 140
“Immune score was calculated from gene expression data using the ESTIMATE algorithm (Yoshihara et al ., 2013) and represents the level of infiltrating immune cells in any given MB sample.”
MethodProteogenomic landscape of squamous cell lung cancer
Stewart, P. A., Welsh, E. A., Slebos, R. J. C., Fang, B., Izumi, V., Chambers, M., Zhang, G., Cen, L., Pettersson, F., Zhang, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11452-x · Cited by 120
Bassiouni, R., Idowu, M. O., Gibbs, L. D., Robila, V., Grizzard, P. J., Webb, M. G., Song, J., Noriega, A., Craig, D. W., & Carpten, J. D. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-2682 · Cited by 143
Gong, H., Liu, Z., Yuan, C., Luo, Y., Chen, Y., Zhang, J., Cui, Y., Zeng, B., Liu, J., Li, H., et al. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108198 · Cited by 128
The Role of Circular RNA CDR1as/ciRS-7 in Regulating Tumor Microenvironment: A Pan-Cancer Analysis
Zou, Y., Zheng, S., Deng, X., Yang, A., Xie, X., Tang, H., & Xie, X. (2019) · Biomolecules · doi:10.3390/biom9090429 · Cited by 129
“To reveal the level of total immune and stromal infiltration, we used the MAlignant Tumors using Expression data (ESTIMATE) algorithm to calculate the immune and stromal score in each sample [20].”
MethodSpratt, D. E., Alshalalfa, M., Fishbane, N., Weiner, A. B., Mehra, R., Mahal, B. A. V., Lehrer, J. M., Liu, Y., Zhao, S. G., Speers, C. W., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1587 · Cited by 130
“Stromal infiltration score was calculated by averaging 141 stromal genes reported previously (12).”
MethodSharma, A., Merritt, E., Hu, X., Cruz, A., Jiang, C., Sarkodie, H., Zhou, Z. M., Malhotra, J. D., Riedlinger, G., & De, S. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.045 · Cited by 140
“ESTIMATE (v1.”
MethodInfluentialPan-cancer proteogenomics connects oncogenic drivers to functional states
Li, Y., Porta‐Pardo, E., Tokheim, C. J., Bailey, M. H., Yaron, T. M., Stathias, V., Geffen, Y., Imbach, K. J., Cao, S., Anand, S. K., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.014 · Cited by 136
Self-citationWinterhoff, B. J. N., Maile, M., Mitra, A., Sebe, A., Bazzaro, M., Geller, M. A., Abrahante, J. E., Klein, M. E., Hellweg, R., Mullany, S. A., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.01.015 · Cited by 140
“Two groups have published gene lists generated by comparing stromal tissue to epithelial tissue using either laser dissection on ovarian cancer samples [15] or by combining data from breast, ovarian and colorectal cancer [16].”
BackgroundYan, H., Qu, J., Cao, W., Liu, Y., Zheng, G., Zhang, E., & Cai, Z. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02408-7 · Cited by 123
Lin, W., Chen, L., Zhang, H., Qiu, X., Huang, Q., Wan, F., Le, Z., Geng, S., Zhang, A., Qiu, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35710-7 · Cited by 133
Wei, J. S., Kuznetsov, I. B., Zhang, S., Song, Y., Asgharzadeh, S., Sindiri, S., Wen, X., Patidar, R., Najaraj, S., Walton, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0599 · Cited by 132
“The immune score was calculated using the ESTIMATE method (24), and 22 immune cell–specific gene sets were derived from a published study (25).”
MethodZeng, D., Fang, Y., Qiu, W., Luo, P., Wang, S., Shen, R., Gu, W., Huang, X., Mao, Q., Wang, G., et al. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100910 · Cited by 141
Alterations in PD-L1 succinylation shape anti-tumor immune responses in melanoma
Liang, L., Kuang, X., He, Y., Zhu, L., Lau, P., Li, X., Luo, D., Gong, L., Zhou, W., Zhang, F., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02077-6 · Cited by 132
Scott, M. C., Temiz, N. A., Sarver, A. E., LaRue, R. S., Rathe, S. K., Varshney, J., Wolf, N. K., Moriarity, B. S., O'Brien, T. D., Spector, L. G., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-0576 · Cited by 113
“we compared results from our method with a previously published tool (ESTIMATE) which infers tumor purity (36).”
An Eight-CircRNA Assessment Model for Predicting Biochemical Recurrence in Prostate Cancer
Wang, S., Su, W., Zhong, C., Yang, T., Chen, W., Chen, G., Liu, Z., Wu, K., Zhong, W., Li, B., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.599494 · Cited by 131
“The result of running the ESTIMATE package (Yoshihara et al., 2013) was conducted to study the difference of microenvironments between the two groups.”
MethodCombinatorial therapy in tumor microenvironment: Where do we stand?
Kumari, S., Advani, D., Sharma, S., Ambasta, R. K., & Kumar, P. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188585 · Cited by 130
Molecular classification of hormone receptor-positive HER2-negative breast cancer
Jin, X., Zhou, Y.-F., Ma, D., Zhao, S., Lin, C., Xiao, Y., Fu, T., Liu, C., Chen, Y., Xiao, W.-X., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01507-7 · Cited by 137
Varadan, V., Gilmore, H., Miskimen, K. L. S., Tuck, D., Parsai, S., Awadallah, A., Krop, I. E., Winer, E. P., Bossuyt, V., Somlo, G., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2021 · Cited by 119
“The Immune Index values for all samples in this study were estimated using the R-package associated with the published algorithm (22).”
MethodInfluentialCross-species oncogenic signatures of breast cancer in canine mammary tumors
Kim, T., Yang, I. S., Seung, B., Lee, S., Kim, D., Ha, Y.-J. J., Seo, M.-K., Kim, K.-K., Kim, H. S., Cheong, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17458-0 · Cited by 128
Self-citationYang, S. Y. C., Lien, S. C., Wang, B. X., Clouthier, D., Hanna, Y., Cirlan, I., Zhu, K., Bruce, J. P., Ghamrasni, S. E., Iafolla, M. A. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25432-7 · Cited by 126
Väremo, L., Scheele, C., Broholm, C., Mardinoglu, A., Kampf, C., Asplund, A., Nookaew, I., Uhlén, M., Pedersen, B. K., & Nielsen, J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.010 · Cited by 116
“We also checked for possible sample contamination of immune cells by using the R-package ESTIMATE (Yoshihara et al., 2013), but again, no pattern was found that could explain the negative correlation of these two datasets with the rest (Figure S1).”
Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases
Priedigkeit, N., Watters, R. J., Lucas, P. C., Basudan, A., Bhargava, R., Horne, W. T., Kolls, J. K., Fang, Z., Rosenzweig, M. Q., Brufsky, A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.95703 · Cited by 133
CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
Gu, Y., Li, X., Bi, Y., Zheng, Y., Wang, J., Li, X., Huang, Z., Chen, L., Huang, Y., & Huang, Y. (2020) · Aging · doi:10.18632/aging.102656 · Cited by 133
“The analysis of immune infiltration by genomic methods is highly influenced by tumor purity in clinical samples [24].”
BackgroundA new risk factor indicator for papillary thyroid cancer based on immune infiltration
Zhou, Y., Wei, X., Pan, Y., Xu, J., Si, Y., Min, Z., & Yu, B. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03294-z · Cited by 122
Lehtiö, J., Arslan, T., Siavelis, I., Pan, Y., Socciarelli, F., Berkovska, O., Umer, H. M., Mermelekas, G., Pirmoradian, M., Jönsson, M., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00259-9 · Cited by 131
“…include: Histology, mRNA subtypes1–3, Stage, Age, Sex, Smoking, Tumor cell content (‘Purity’), Immune and Stromal Signatures as described in (Yoshihara et al. 2013), TMB calculated from panel sequencing data, selected putative functional mutations from panel sequencing analysis, PD-L1…”
MethodFeng, S., Xu, Y., Dai, Z., Yin, H., Zhang, K., & Shen, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.951582 · Cited by 128
“Cancer-Associated Fibroblasts and Stromal Analysis CAF abundances and stromal scores were computed using four methods: Estimate the Proportion of Immune and Cancer cells (EPIC) algorithm (24), xCell algorithm (25), microenvironment cell populations-counter (MCP-counter) algorithm (26), and Estimation of Stromal and Im…”
MethodWang, W., Lu, Z., Wang, M., Liu, Z., Wu, B., Yang, C., He, H., & Gong, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.998236 · Cited by 139
“Frontiers in Immunology 03 Estimation of Stromal and Immune cells in Malignant Tumor tissues using Expression) algorithm (29).”
MethodLiu, K., Newbury, P. A., Glicksberg, B. S., Zeng, B., Paithankar, S., Andrechek, E. R., & Chen, B. (2019) · Nature Communications · doi:10.1038/s41467-019-10148-6 · Cited by 130
Zhu, L., Narloch, J. L., Onkar, S., Joy, M., Broadwater, G., Luedke, C., Hall, A. H. S., Kim, R., Pogue–Geile, K. L., Sammons, S. L., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0755-1 · Cited by 126
“We inferred the immune abundance from RNAseq data using single-sample gene set enrichment analysis (ssGSEA, i.e. immune score in ESTIMATE) [10], gene set variation analysis (GSVA) [11] and deconvolution methods --- CIBERSORT [12] and TIMER [13].”
MethodLinxweiler, M., Kuo, F., Katabi, N., Lee, M., Nadeem, Z., Dalin, M. G., Makarov, V., Chowell, D., Doğan, S., Ganly, I., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3758 · Cited by 120
“Estimation of Stromal and Immune Cells inMalignant TumorTissues using ExpressionData (ESTIMATE) is an ssGSEA-based technique, in which differential gene expression from high and low immune cell–infiltrating tumor samples is used to derive a 141-gene signature estimating the degree of stromal and immune infiltration in…”
MethodInfluentialVellinga, T. T., den Uil, S., Rinkes, I. H. B., Marvin, D., Ponsioen, B., Alvarez-Varela, A., Fatrai, S., Scheele, C., Zwijnenburg, D. A., Snippert, H., et al. (2016) · Oncogene · doi:10.1038/onc.2016.60 · Cited by 115
“23 There was an excellent correlation between the Estimate gene set and the SGF in three independent large colon tumor datasets (Figure 1d).”
Karlsson, A., Jönsson, M., Lauss, M., Brunnström, H., Jönsson, P., Borg, Å., Jönsson, G. B., Ringnér, M., Planck, M., & Staaf, J. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1087 · Cited by 120
“Supporting these observations, we found similar patterns of stromal and immune expression scores between the epitypes using the Estimation of Stromal and Immune Cells in Malignant Tumors (ESTIMATE) method (28) in both cohorts (data not shown).”
MethodMultigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma
Hu, X., Martínez-Ledesma, E., Zheng, S., Kim, H., Barthel, F. P., Jiang, T., Hess, K. R., & Verhaak, R. G. W. (2017) · Neuro-Oncology · doi:10.1093/neuonc/now285 · Cited by 116
Self-citationYTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
Hu, J. M., Qiu, D., Yu, A., Hu, J., Deng, H., Li, H., Yi, Z., Chen, J., & Zu, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.607224 · Cited by 131
“for predicting tumor purity in TME, and this algorithm included stromal score (that captures the presence of stroma 136 in tumor tissue), immune score (that represents the infiltration of immune cells in tumor 137 tissue), and estimate score (that infers tumor purity) (30).”
BackgroundIntegrated proteogenomic characterization of urothelial carcinoma of the bladder
Xu, N., Yao, Z., Shang, G., Ye, D., Wang, H., Zhang, H., Qu, Y., Xu, F., Wang, Y., Qin, Z., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01291-7 · Cited by 109
“These molecularly based cell-type classifications were supported by ESTIMATE analysis [51] (Methods; Additional file 18: Table S6), yielding the Pearson correlation coefficients of 0.”
MethodLi, Z., Zheng, Z., Wei, Z.-H., Zhang, L., Li, F., Lin, L., Liu, R., Huang, X., Lv, J., Chen, F., et al. (2019) · Theranostics · doi:10.7150/thno.36585 · Cited by 139
“Immune and stromal scores were calculated to quantify the immune and stromal components in a tumor by using ESTIMATE algorithm [27].”
MethodLung metastases share common immune features regardless of primary tumor origin
García‐Mulero, S., Alonso, M. H., Pardo, J., Santos, C., Sanjuán, X., Salazar, R., Moreno, V. R., Piulats, J. M., & Pamplona, R. S. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000491 · Cited by 124
“Gene Set Variation Analysis from R package GSVA was”
Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment
Xie, Z., Li, X., He, Y., Wu, S., Wang, S., Sun, J., He, Y., Lun, Y., & Zhang, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.570604 · Cited by 135
“org 3 ESTIMATE ESTIMATE was used to evaluate the composition of the TME for each THCA sample (24) and included immune score (immune cell infiltration), stromal score (stromal content), ESTIMATE score (stromal-immune comprehensive score) and tumor purity.”
MethodYu, T., Ma, D., Liu, Y., Xiao, Y., Gong, Y., Jiang, Y., Shao, Z.-M., Hu, X., & Di, G. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.003 · Cited by 127
The role of ferroptosis in breast cancer patients: a comprehensive analysis
Wu, Z., Tang, Y., Yu, H., & Li, H. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00473-5 · Cited by 128
Chen, H., Yang, W., Li, Y., Ma, L., & Ji, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1198878 · Cited by 131
“TIME scores including stromal, immune, and ESTIMATE scores were determined by the “ESTIMATE” package (19).”
MethodWei, C., Liang, Q., Li, X., Li, H., Liu, Y., Huang, X., Chen, X., Guo, Y., & Li, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28754 · Cited by 113
“Immune cells, known as tumor killers, are able to perturb the molecular signal and play crucial roles in cancer biology, including those closely related to tumor proliferation, metastasis, and invasion.(3,4) Nevertheless, some cancer cells are able to avoid detection by the immune system; to repress immune responses,…”
BackgroundMethodMicroscaled proteogenomic methods for precision oncology
Satpathy, S., Jaehnig, E. J., Krug, K., Kim, B.-J., Saltzman, A. B., Chan, D. W., Holloway, K. R., Anurag, M., Huang, C., Singh, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14381-2 · Cited by 111
McKerrow, W., Wang, X., Mendez-Dorantes, C., Mita, P., Cao, S., Grivainis, M., Ding, L., LaCava, J., Burns, K. H., Boeke, J. D., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2115999119 · Cited by 104
Integrating Clinical and Multiple Omics Data for Prognostic Assessment across Human Cancers
Zhu, B., Song, N., Shen, R., Arora, A., Machiela, M. J., Song, L., Landi, M. T., Ghosh, D., Chatterjee, N., Baladandayuthapani, V., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17031-8 · Cited by 109
Yang, S. Y. C., Lheureux, S., Karakasis, K., Burnier, J. V., Bruce, J. P., Clouthier, D., Danesh, A., Quevedo, R., Dowar, M., Hanna, Y., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0590-x · Cited by 122
“To assess relationships of immune cell infiltration with survival, we assessed enrichment of four published gene expression subtypes (including an immuneoreactive subtype, IMR) [26] as well as a total immune cell infiltration score (ESTIMATE algorithm) [27] in 29 tumors with available RNA-seq data (13 LT and 16 ST).”
MethodAvalle, L., Raggi, L., Monteleone, E., Savino, A., Viavattene, D., Statello, L., Camperi, A., Stabile, S. A., Salemme, V., Marzo, N. D., et al. (2022) · Oncogene · doi:10.1038/s41388-021-02172-y · Cited by 120
“stromal content using ssGSEA and stromal/immune signatures [26] (Supplementary Fig.”
MethodMolecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal Cancer
Bramsen, J. B., Rasmussen, M. H., Ongen, H., Mattesen, T. B., Ørntoft, M.-B. W., Árnadóttir, S. S., Sandoval, J., Laguna, T., Vang, S., Øster, B., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.045 · Cited by 110
Chen, Q., Han, B., Meng, X., Duan, C., Yang, C., Wu, Z., Magafurov, D., Zhao, S., Safin, S., Jiang, C., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32102 · Cited by 109
“databases To investigate the underlying molecules involved in glioma microenvironment, we built six glioma microenvironment signatures containing mature vascular signature (Mature vascular), microvascular signature (Microvascular), hypoxia activation signature (Hypoxia activation),(21) tumour purity, stromal and immun…”
MethodLiu, Z., Mi, M., Li, X., Zheng, X., Wu, G., & Zhang, L. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15762 · Cited by 131
Pan, J. W., Zabidi, M. M. A., Ng, P.-S., Meng, M., Hasan, S. N., Sandey, B., Sammut, S., Yip, C. H., Rajadurai, P., Rueda, O. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20173-5 · Cited by 127
Huang, K. K., Ma, H., Chong, R. H. H., Uchihara, T., Lian, B. S. X., Zhu, F., Sheng, T., Srivastava, S., Tay, S. T., Sundar, R., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.10.004 · Cited by 121
Self-citationPeng, Y., Liu, C., Li, M., Li, W., Zhang, M., Jiang, X. W., Chang, Y., Liu, L., Wang, F., & Zhao, Q. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01792-4 · Cited by 126
“We applied the "Estimation of Stromal and Immune cells in Malignant Tumours using Expression data" (ESTIMATE) algorithm to assess the immune scores, stromal scores, estimate scores, and tumor purity for each HCC sample [30].”
MethodSun, H., Cao, S., Mashl, R. J., Mo, C.-K., Zaccaria, S., Wendl, M. C., Davies, S. R., Bailey, M. H., Primeau, T. M., Hoog, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25177-3 · Cited by 113
Metadata
- Authors
- Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., Carter, S. L., Getz, G., Stemke-Hale, K., Mills, G. B., & Verhaak, R. G. W.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Southern California (US)
- Memorial Sloan Kettering Cancer Center (US)
- Broad Institute (US)
- Corresponding author
- Verhaak, Roel G.W.
- ORCID
- Venue
- Nature Communications
- Published
- 2013-10-11
- Volume
- 4
- Issue
- 1
- Pages
- 2612-2612
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3826632
- OpenAlex
- W2130430382
- Cited by
- 9,778
- References
- 63
- Citations by year
- 2026: 694 · 2025: 1176 · 2024: 1602 · 2023: 1755 · 2022: 1988 · 2021: 1316 · 2020: 683 · 2019: 223 · 2018: 121 · 2017: 93 · 2016: 53 · 2015: 39 · 2014: 20 · 2013: 2
- FWCI
- 17.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Communications (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (P50CA098258, U24CA143882, CA143883, U24CA143883, P30CA008748, P30CA016672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- tumor purity, tumor stroma, tumor-infiltrating immune cells, gene expression signatures, tumor microenvironment, DNA copy number, cancer transcriptomics
- MeSH terms
- Algorithms, Cell Separation, Female, Humans, Leukocytes, Neoplasms, Research Design, Sensitivity and Specificity, Software, Gene Library, Genome, Human, Stromal Cells, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, DNA Copy Number Variations, High-Throughput Nucleotide Sequencing, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.